Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2010-A00385-34 | Other Identifier | AFSSAPS (ANSM) |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Sanofi Pasteur, a Sanofi Company | INDUSTRY |
| Institut National de la Santé Et de la Recherche Médicale, France | OTHER_GOV |
| Clinique Antilles-Guyane | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Dengue is an infectious disease most prevalent in the world. This disease is endemic in the Caribbean, with an increase in seasonal rains. Several outbreaks have been observed in recent years, in 2001, 2005 and 2007, during which further particularly virulent serotypes have emerged. The clinical expression of dengue fever is variable, ranging from no symptoms to a classical form with fever, and even of severe or lethal bleeding. With the possible existence of silent forms of the disease, there are no data identifying the current level of protection of the population in Martinique / Guadeloupe.
Principal objective:
To estimate the prevalence of the specific antibodies of the dengue (IgG) in blood donors in the French West Indies.
Secondary objective:
To specify the serotypic specificity of the anti-dengue antibodies detected during the study.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Biological sample collection | Other | Blood (serum) sample collection |
| Measure | Description | Time Frame |
|---|---|---|
| Presence or not of dengue virus-specific immunoglobulin G antibodies | 1 day |
| Measure | Description | Time Frame |
|---|---|---|
| Characterization of dengue virus serotype-specific IgG | Characterization of dengue virus serotype-psecific IgG whendengue virus serotype-specific immunoglobulin G antibodies Test is positive | 1 day |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Adult, résidents in Martinique/ Guadeloupe (french west indies), aged 18 to 65 years coming to give their blood in one of the building or mobile collection facilities of the French Blood Establishment in French West Indies.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Pascale RICHARD, MD | French Blood Establishment of Martinique | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| French Blood Establishment of Guadeloupe | Pointe-à-Pitre | 97171 | Guadeloupe | |||
| French Blood Establishment of Martinique |
Not provided
| ID | Term |
|---|---|
| D003715 | Dengue |
| ID | Term |
|---|---|
| D000096724 | Mosquito-Borne Diseases |
| D000079426 | Vector Borne Diseases |
| D007239 | Infections |
| D001102 | Arbovirus Infections |
Not provided
Not provided
Not provided
Not provided
Not provided
serum
| Fort-de-France |
| 97264 |
| Martinique |
| D014777 |
| Virus Diseases |
| D018177 | Flavivirus Infections |
| D018178 | Flaviviridae Infections |
| D012327 | RNA Virus Infections |
| D006482 | Hemorrhagic Fevers, Viral |